Protection by 4th dose of BNT162b2 against Omicron in Israel

Yinon M. Bar-On, Yair Goldberg, Micha Mandel, Omri Bodenheimer, Ofra Amir, Laurence Freedman, Sharon Alroy-Preis, Nachman Ash, Amit Huppert, Ron Milo
doi: https://doi.org/10.1101/2022.02.01.22270232

Article Information

doi 
https://doi.org/10.1101/2022.02.01.22270232
History 
  • February 1, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Yinon M. Bar-OnϮ,1,
  2. Yair GoldbergϮ,2,*,
  3. Micha MandelϮ,3,
  4. Omri Bodenheimer4,
  5. Ofra Amir2,
  6. Laurence Freedman5,
  7. Sharon Alroy-Preis4,
  8. Nachman Ash4,
  9. Amit Huppert&,5,6 and
  10. Ron Milo&,1
  1. 1Department of Plant and Environmental Sciences, Weizmann Institute of Science, Israel
  2. 2Technion - Israel Institute of Technology, Israel
  3. 3The Hebrew University of Jerusalem, Israel
  4. 4Israel Ministry of Health, Israel
  5. 5The Bio-statistical and Bio-mathematical Unit, The Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Israel
  6. 6The Faculty of Medicine, Tel Aviv University, Israel
  1. ↵*corresponding author email: yairgo{at}technion.ac.il

  1. ↵Ϯ Contributed equally.

  2. ↵& Contributed equally.

Back to top
Posted February 01, 2022.
Download PDF
Data/Code
Email
Protection by 4th dose of BNT162b2 against Omicron in Israel
Yinon M. Bar-On, Yair Goldberg, Micha Mandel, Omri Bodenheimer, Ofra Amir, Laurence Freedman, Sharon Alroy-Preis, Nachman Ash, Amit Huppert, Ron Milo
medRxiv 2022.02.01.22270232; doi: https://doi.org/10.1101/2022.02.01.22270232
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area